Enzyme PARG identified as a new target to enhance chemotherapy in colorectal cancer

Colorectal cancer is one of the most prevalent tumors and a leading cause of cancer-related mortality. Despite advances achieved in recent years, resistance to available treatments remains one of the main clinical challenges, particularly in advanced stages of the disease.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup